The price set by the Swiss drugmaker Novartis may be the world’s highest for a single treatment — prompting renewed debate about how society will pay for gene-therapy breakthroughs.

from Health https://nyti.ms/2Ew6vFX

Related Posts:

0 comments:

Post a Comment

Popular Posts